Research Fellow of the year (2021-2022), Department o...
ASCO Conquer Cancer Merit Award, 2022, 2023
EHA Travel Grant Award, 2022
ASH Abstract Achievement Award 2023
Research Fellow of the year (2021-2022), Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston,
Clinical Fellow of the year (2022-2023), Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston,
Hematocon (ISHBT) 2016 first prize for best oral paper in malignant clinical hematology
Short NJ, Senapati J, Jabbour E. An Update on the Management of Advanced Phase Chronic Myeloid Leukemia. Curr Hematol Malig Rep. 2023.
Senapati J, Panda T, Rajendra A, Aggarwal M. Understanding the barriers to AML care in India. The Lancet Haematology. 2023;10(9):e710-e1.
Senapati J, Fiskus WC, Daver N, et al. Phase 1 Results of Bromodomain and Extraterminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies. Clin Cancer Res 2023 (In eng). DOI: 10.1158/1078-0432.Ccr-23-1429.
Senapati J, Urrutia S, Loghavi S, et al. Venetoclax Abrogates the Prognostic Impact of Splicing Factor Gene Mutations in Newly Diagnosed Acute Myeloid Leukemia. Blood 2023 (In eng). DOI: 10.1182/blood.2023020649